APTBIO
Shanghai
About APTBIO
APTBIO was initiated by Shanghai Institutes for Biological Sciences under Chinese Academy of Sciences in 2004, and is mainly engaged in the application of mass spectrometry technology. The so-called mass spectrometry technology is to measure the quality of protein molecules to carry out the identification of protein molecules, the modification of protein molecules and the study of protein molecule interactions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $28.3M
- Funding stage: Late Stage Venture
- Last round: Series C (Apr 2024)
- Website: aptbiotech.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/aptbio-153344 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.